Clinical Trial Update: Sole-Therapy Treatment of Atrial Fibrillation [Phase 2]

View source ↗

Summary

An update on a Phase 2 trial evaluating Sole-Therapy for treating atrial fibrillation conducted by AtriCure, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• Sole-Therapy

Snippet

Sponsor: AtriCure, Inc. | Conditions: Atrial Fibrillation | Phase 2 | Status: UNKNOWN